The forces shaping markets and the economy are often hiding behind a blur of numbers.

So that's why we created The Big Take from Bloomberg Podcasts, to give you the context you need to make sense of it all.

Every day in just 15 minutes, we dive into one global business story that matters.

You'll hear from Bloomberg journalists like Matt Levine.

A lot of this meme stock stuff is, I think, embarrassing to the SEC.

Follow the Big Take podcast on the IHeart Radio app, Apple Podcasts, or wherever you listen.

Welcome to Prognosis.

I'm Laura Carlson.

It's day 128 since coronavirus was declared a global pandemic.

Today's main story, much has been made about the race to develop a vaccine and who will win it.

But being first isn't the only thing that matters in the rush to inoculate us from COVID-19.

But first, here's what happened in virus news today.

All of the U.S. government programs set to offset the economic hit from the coronavirus are about to expire.

More than $2 trillion in government spending was approved to support hard-hit businesses and unemployed people earlier this year.

Now, leaders face an urgent set of decisions about whether to extend history's biggest rescue effort.

The Trump administration wants another relief bill, with a price tag of no more than $1 trillion

before lawmakers leave for summer recess in early August.

The Democrat-controlled House already approved additional measures

worth $3.5 trillion, but Republicans, who have a Senate majority, oppose many of them.

New York City is ready to enter the fourth and final phase of reopening Monday, Mayor Bill de Blasio said. Zoos, botanical gardens, and outdoor movie production

can resume, but indoor dining, museums, and malls will remain closed.

Hospitalizations in the state of New York dropped to a four-month low,

...